Mallinckrodt shares slide 4% premarket after pain treatment approval delayed - MarketWatch https://t.co/5ZDo1wyyvt
— IDRO (@IDROOhio) December 12, 2018
from Twitter https://twitter.com/IDROOhio
December 12, 2018 at 04:55AM
Wednesday, December 12, 2018
Mallinckrodt shares slide 4% premarket after pain treatment approval delayed - MarketWatch https://t.co/5ZDo1wyyvt
from Twitter https://twitter.com/IDROOhio
December 12, 2018 at 04:55AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment